MK-4074

MK-4074 · Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-4074, covering 2016-03-25 to 2016-03-25. Get the full timeline:

Most recent: Clinical Trial Update: Study of Changes in Hepatic Fat Following Administration of MK-4074 and Pioglitazone Hydrochloride (MK-4074-008) [Phase 1]

See pricing